Novartis launches Arcapta(TM) Neohaler(TM), a novel once-daily bronchodilator … – MarketWatch (press release)

Novartis launches Arcapta(TM) Neohaler(TM), a novel once-daily bronchodilator
MarketWatch (press release)
Arcapta Neohaler is not indicated to treat asthma. It is also not indicated to treat acute deteriorations of COPD and should not be used as a rescue medication for acute symptoms. Arcapta Neohaler is the only once-daily, 24-hour long-acting

and more »

View full post on asthma – Google News

MediciNova and University of Colorado Boulder Collaborate on Potential Novel … – MarketWatch (press release)

MediciNova and University of Colorado Boulder Collaborate on Potential Novel
MarketWatch (press release)
Ibudilast has been used in asthma and post-stroke disorders in Japan for around 20 years. MediciNova has demonstrated utility of ibudilast in neurological disorders at higher doses with encouraging outcomes in company-sponsored clinical trials in

and more »

View full post on asthma – Google News

Actelion’s novel CRTH2 antagonist meets primary endpoint in Phase II study in … – Reuters (press release)

Actelion's novel CRTH2 antagonist meets primary endpoint in Phase II study in
Reuters (press release)
This study complements the positive proof-of-mechanism study in asthma reported in 2009. Together, these studies provide substantial information that will guide us in the further development of this compound and our follow-up molecules in allergic

and more »

View full post on asthma – Google News

Novel biomarkers may aid in diagnosis and management of asthma, COPD – News-Medical.net

Novel biomarkers may aid in diagnosis and management of asthma, COPD
News-Medical.net
Four novel biomarkers have been identified which may aid in the diagnosis and management of asthma and chronic obstructive pulmonary disease (COPD), according to a study conducted by researchers in Australia, who determined the biomarkers may be used

and more »

View full post on asthma – Google News

Four novel biomarkers that may help diagnose asthma, COPD identified – Sify

Four novel biomarkers that may help diagnose asthma, COPD identified
Sify
Researchers in Australia have identified four novel biomarkers that may aid in the diagnosis and management of asthma and chronic obstructive pulmonary disease (COPD). According to a study the biomarkers may be used in different combinations to
New Technique May Help Diagnose Asthma, COPDWebMD
Biomarker Panel Identifies Asthma, COPDMedscape
Researchers link novel biomarkers to asthma and COPDEurekAlert (press release)

all 10 news articles »

View full post on asthma – Google News

Novel Gentic Variations Contributing to Asthma Susceptability in Saudi Arabia

Conditions:   Collection of Clinical Data That Will be Used in This Study and Will Form a Data Bank for Asthma in Saudi Arabia;   Identify Known and NOVEL Genetic Risk Factors Contributing to Asthma Susceptibility;   Study the Mechanistic Roles of the Genetic Variants Within Major Asthma Susceptibility Genes
Intervention:  
Sponsor:   King Saud University
Recruiting – verified April 2010

View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days

ASNC: Novel Imaging Agent Safe in Airway Disease Patients – MedPage Today

ASNC: Novel Imaging Agent Safe in Airway Disease Patients
MedPage Today
PHILADELPHIA — A novel pharmacologic stress agent for myocardial perfusion imaging, apadenoson (Stedivaze), was well tolerated in patients with asthma and
Lexiscan® (Regadenoson) Injection Study in Subjects With Asthma or Chronic PR Newswire (press release)

all 12 news articles »

View full post on asthma – Google News